Human biology is not black and white. Although newborns are typically categorized as male or female at birth based on visible ...

"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...

An expert discusses what has been learned about the use of bone-protecting agents and bone density scans for patients ...

Dealing with unwanted chin hair can be a constant battle, especially when waxing, threading, or laser treatments only offer ...

It seems the Trump administration is arguing that people like me are neither male nor female but simply ‘disordered,’” writes Kimberly Zieselman.

Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...

A cancer drug developed ten years ago at UCSF can also put the brakes on one of prostate cancer's deadliest molecular tricks.

Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of ...

Spironolactone's safety profile had been primarily generated from trials of older people with heart failure, so its safety in ...

Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).

Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...

Hypospadias is characterized by an ectopic urethral opening and abnormal penile curvature, affecting approximately 1 in 200 live male births.